The Menopause Metabolic Protocol: Targeting the Three Root Causes
How MOTS-c, 5-Amino-1MQ, SS-31, and BPC-157 address inflammation, insulin resistance, and ATP shortage
Key Findings
- 1Menopause triggers metabolic dysfunction through three overlapping root causes
- 2MOTS-c targets mitochondrial signaling and may mimic exercise at the cellular level
- 35-Amino-1MQ inhibits the NNMT enzyme, supporting NAD+ recycling and metabolic flexibility
- 4SS-31 (Elamipretide) directly targets mitochondrial membrane integrity and ATP production
- 5BPC-157 addresses the inflammatory cascade that accelerates metabolic aging
Why Menopause Breaks Metabolism
Menopause doesn't just reduce estrogen — it disrupts the entire metabolic system through three interconnected root causes. Understanding these is the key to building an effective protocol.
The Three Root Causes
- Inflammation — estrogen decline removes a major anti-inflammatory signal, leading to chronic systemic inflammation (elevated CRP, joint pain, brain fog)
- Insulin Resistance — metabolic signaling shifts toward fat storage, especially visceral fat; glucose tolerance decreases; energy crashes become frequent
- ATP Shortage — mitochondrial efficiency declines sharply; cellular energy production drops; recovery time increases; exercise tolerance falls
Most interventions target only ONE root cause. This protocol addresses all three simultaneously — which is why it produces compound (no pun intended) results.
The Four-Compound Stack
The four compounds and their roles:
- MOTS-c — Mitochondrial-derived peptide that activates AMPK signaling, the same pathway triggered by exercise. Improves metabolic flexibility, glucose uptake, and fat oxidation. (Evidence: experimental)
- 5-Amino-1MQ — NNMT enzyme inhibitor. Blocks the enzyme that depletes NAD+ and promotes visceral fat storage. Supports metabolic efficiency and cellular energy recycling. (Evidence: experimental)
- SS-31 (Elamipretide) — Targets cardiolipin in the inner mitochondrial membrane, stabilizing the electron transport chain and restoring ATP production. One of the few compounds with direct mitochondrial access. (Evidence: clinical trials)
- BPC-157 — Anti-inflammatory peptide that modulates TNF-alpha, IL-6, and nitric oxide pathways. Addresses the chronic inflammatory cascade triggered by estrogen decline. Injectable only — oral is ineffective. (Evidence: clinical)
The specific doses, timing, cycling schedule, and ramp-up protocol for this menopause stack depend on your hormone profile, symptoms, and goals. DoseCraft's AI coach builds personalized menopause protocols from leading clinical practitioners. → Build your menopause protocol in DoseCraft (https://app.dosecraftapp.com/protocols/builder)
Protocol Timeline
This protocol uses a phased ramp-up approach with specific cycling windows for each compound — not all four start simultaneously. The exact timeline, dose titration, and cycling schedule are available inside the DoseCraft app, where the AI coach tailors the protocol to your bloodwork and symptom profile.
Track This Protocol
Log doses, monitor interactions, and optimize your stack with AI tools.
Open DoseCraftSource Compounds
Pharma-grade, third-party tested. Our preferred vendor for the DoseCraft community.
Shop Peptide PartnersWhy This Combination Works
Each compound targets a different root cause, but they also create synergistic effects. MOTS-c and SS-31 both improve mitochondrial function through different mechanisms (AMPK activation vs. membrane stabilization). 5-Amino-1MQ supports the NAD+ pool that both mitochondrial peptides depend on. And BPC-157 reduces the inflammatory load that accelerates all three root causes. The result is a protocol where each compound amplifies the others.
This article is for educational purposes only. This is not a prescription. Consult a licensed healthcare professional before starting any peptide protocol, especially during menopause when hormonal changes affect drug metabolism.
Put this research into action
Track your protocol with precision tools. Source pharma-grade compounds from a trusted vendor.
Track in DoseCraft
Build this protocol in 60 seconds. AI-powered dose logging, half-life tracking, and interaction checks.
Open Protocol BuilderGet the Compounds
Pharma-grade, third-party tested peptides from our preferred vendor. Trusted by the community.
Shop Peptide PartnersNot medical advice — educational only. DoseCraft is an information and personal tracking platform. We do not provide medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting any protocol. Affiliate links may be present — we only recommend vendors we trust.